A citation-based method for searching scientific literature


List of co-cited articles
76 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
Milena Sant, Claudia Allemani, Carmen Tereanu, Roberta De Angelis, Riccardo Capocaccia, Otto Visser, Rafael Marcos-Gragera, Marc Maynadié, Arianna Simonetti, Jean-Michel Lutz,[...]. Blood 2010
536
55

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.
Marc Maynadié, Roberta De Angelis, Rafael Marcos-Gragera, Otto Visser, Claudia Allemani, Carmen Tereanu, Riccardo Capocaccia, Adriano Giacomin, Jean-Michel Lutz, Carmen Martos,[...]. Haematologica 2013
51
27

Standard cancer patient population for age standardising survival ratios.
Isabella Corazziari, Mike Quinn, Riccardo Capocaccia. Eur J Cancer 2004
386
27

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
Roberta De Angelis, Milena Sant, Michel P Coleman, Silvia Francisci, Paolo Baili, Daniela Pierannunzio, Annalisa Trama, Otto Visser, Hermann Brenner, Eva Ardanaz,[...]. Lancet Oncol 2014
27

The relative survival rate: a statistical methodology.
F EDERER, L M AXTELL, S J CUTLER. Natl Cancer Inst Monogr 1961
805
22

Incidence, survival and prevalence of myeloid malignancies in Europe.
O Visser, A Trama, M Maynadié, C Stiller, R Marcos-Gragera, R De Angelis, S Mallone, C Tereanu, C Allemani, U Ricardi,[...]. Eur J Cancer 2012
132
22

Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
Gemma Gatta, Laura Botta, Silvia Rossi, Tiiu Aareleid, Magdalena Bielska-Lasota, Jacqueline Clavel, Nadya Dimitrova, Zsuzsanna Jakab, Peter Kaatsch, Brigitte Lacour,[...]. Lancet Oncol 2014
585
22

On estimation in relative survival.
Maja Pohar Perme, Janez Stare, Jacques Estève. Biometrics 2012
365
22


Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses.
Anna Gavin, Brian Rous, Rafael Marcos-Gragera, Richard Middleton, Eva Steliarova-Foucher, Marc Maynadie, Roberto Zanetti, Otto Visser. Eur J Cancer 2015
15
26

The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.
Silvia Rossi, Paolo Baili, Riccardo Capocaccia, Massimiliano Caldora, Eugenio Carrani, Pamela Minicozzi, Daniela Pierannunzio, Mariano Santaquilani, Annalisa Trama, Claudia Allemani,[...]. Eur J Cancer 2015
76
22

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Milena Sant, Pamela Minicozzi, Morgane Mounier, Lesley A Anderson, Hermann Brenner, Bernd Holleczek, Rafael Marcos-Gragera, Marc Maynadié, Alain Monnereau, Gemma Osca-Gelis,[...]. Lancet Oncol 2014
186
22

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Claudia Allemani, Hannah K Weir, Helena Carreira, Rhea Harewood, Devon Spika, Xiao-Si Wang, Finian Bannon, Jane V Ahn, Christopher J Johnson, Audrey Bonaventure,[...]. Lancet 2015
22

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
Jennifer J Turner, Lindsay M Morton, Martha S Linet, Christina A Clarke, Marshall E Kadin, Claire M Vajdic, Alain Monnereau, Marc Maynadié, Brian C-H Chiu, Rafael Marcos-Gragera,[...]. Blood 2010
180
16

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Lindsay M Morton, Sophia S Wang, Susan S Devesa, Patricia Hartge, Dennis D Weisenburger, Martha S Linet. Blood 2006
16

The cancer survival gap between elderly and middle-aged patients in Europe is widening.
Alberto Quaglia, Andrea Tavilla, Lorraine Shack, Hermann Brenner, Maryska Janssen-Heijnen, Claudia Allemani, Marc Colonna, Enrico Grande, Pascale Grosclaude, Marina Vercelli. Eur J Cancer 2009
143
16

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).
Lindsay M Morton, Jennifer J Turner, James R Cerhan, Martha S Linet, Patrick A Treseler, Christina A Clarke, Andrew Jack, Wendy Cozen, Marc Maynadié, John J Spinelli,[...]. Blood 2007
308
16


Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Alain Monnereau, Xavier Troussard, Aurélien Belot, Anne-Valérie Guizard, Anne-Sophie Woronoff, Simona Bara, Bénédicte Lapôtre-Ledoux, Jean Iwaz, Brigitte Tretarre, Marc Maynadié. Int J Cancer 2013
44
16

Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.
Gemma Osca-Gelis, Montserrat Puig-Vives, Marc Saez, David Gallardo, Natalia Lloveras, Rafael Marcos-Gragera. Haematologica 2013
17
17

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience.
Hagop Kantarjian, Susan O'Brien, Elias Jabbour, Guillermo Garcia-Manero, Alfonso Quintas-Cardama, Jenny Shan, Mary Beth Rios, Farhad Ravandi, Stefan Faderl, Tapan Kadia,[...]. Blood 2012
222
16

Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group.
Saskia Mostert, Ramandeep Singh Arora, Magda Arreola, Poonam Bagai, Paola Friedrich, Sumit Gupta, Geetinder Kaur, Bindu Koodiyedath, Ketan Kulkarni, Catherine G Lam,[...]. Lancet Oncol 2011
157
16


Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
Martin Höglund, Fredrik Sandin, Karin Hellström, Mats Björeman, Magnus Björkholm, Mats Brune, Arta Dreimane, Marja Ekblom, Sören Lehmann, Per Ljungman,[...]. Blood 2013
87
16


International Classification of Childhood Cancer, third edition.
Eva Steliarova-Foucher, Charles Stiller, Brigitte Lacour, Peter Kaatsch. Cancer 2005
938
16

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
Laurie H Sehn, Jane Donaldson, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Richard Klasa, Nicol MacPherson, Susan O'Reilly, John J Spinelli, Judy Sutherland,[...]. J Clin Oncol 2005
754
11

Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
Franco Berrino, Roberta De Angelis, Milena Sant, Stefano Rosso, Magdalena Bielska-Lasota, Jan W Coebergh, Mariano Santaquilani. Lancet Oncol 2007
607
11

The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis.
Roberta De Angelis, Silvia Francisci, Paolo Baili, Francesca Marchesi, Paolo Roazzi, Aurélien Belot, Emanuele Crocetti, Pierre Pury, Arnold Knijn, Michel Coleman,[...]. Eur J Cancer 2009
113
11

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.
Rafael Marcos-Gragera, Claudia Allemani, Carmen Tereanu, Roberta De Angelis, Riccardo Capocaccia, Marc Maynadie, Stefano Luminari, Stefano Ferretti, Tom Børge Johannesen, Risto Sankila,[...]. Haematologica 2011
51
11

The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
Karen J Phekoo, Mike A Richards, Henrik Møller, Steve A Schey. Haematologica 2006
80
11

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Bertrand Coiffier, Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard,[...]. N Engl J Med 2002
11


Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
Brian J Druker, François Guilhot, Stephen G O'Brien, Insa Gathmann, Hagop Kantarjian, Norbert Gattermann, Michael W N Deininger, Richard T Silver, John M Goldman, Richard M Stone,[...]. N Engl J Med 2006
11

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
Stephen G O'Brien, François Guilhot, Richard A Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy Hughes,[...]. N Engl J Med 2003
11

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.
Dana E Rollison, Nadia Howlader, Martyn T Smith, Sara S Strom, William D Merritt, Lynn A Ries, Brenda K Edwards, Alan F List. Blood 2008
438
11

Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005.
Asa Rangert Derolf, Sigurdur Yngvi Kristinsson, Therese M-L Andersson, Ola Landgren, Paul W Dickman, Magnus Björkholm. Blood 2009
104
11

Delivering affordable cancer care in high-income countries.
Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F Tannock,[...]. Lancet Oncol 2011
464
11



Cancer survival in five continents: a worldwide population-based study (CONCORD).
Michel P Coleman, Manuela Quaresma, Franco Berrino, Jean-Michel Lutz, Roberta De Angelis, Riccardo Capocaccia, Paolo Baili, Bernard Rachet, Gemma Gatta, Timo Hakulinen,[...]. Lancet Oncol 2008
798
11


Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.
Claudia Allemani, Bernard Rachet, Hannah K Weir, Lisa C Richardson, Côme Lepage, Jean Faivre, Gemma Gatta, Riccardo Capocaccia, Milena Sant, Paolo Baili,[...]. BMJ Open 2013
59
11

A reducible four-parameter system of model life tables.
D C Ewbank, J C Gomez De Leon, M A Stoto. Popul Stud (Camb) 1983
31
11

Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
Camille Maringe, Sarah Walters, Bernard Rachet, John Butler, Tony Fields, Paul Finan, Roy Maxwell, Bjørn Nedrebø, Lars Påhlman, Annika Sjövall,[...]. Acta Oncol 2013
145
11

A 50-year journey to cure childhood acute lymphoblastic leukemia.
Ching-Hon Pui, William E Evans. Semin Hematol 2013
188
11

Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.
Shang-Ju Wu, Chun-Ju Chiang, Chien-Ting Lin, Hwei-Fang Tien, Mei-Shu Lai. PLoS One 2013
17
11

An approach to estimation in relative survival regression.
Maja Pohar Perme, Robin Henderson, Janez Stare. Biostatistics 2009
37
11

Control of data quality for population-based cancer survival analysis.
Ruoran Li, Louise Abela, Jonathan Moore, Laura M Woods, Ula Nur, Bernard Rachet, Claudia Allemani, Michel P Coleman. Cancer Epidemiol 2014
19
11

A scandal of invisibility: making everyone count by counting everyone.
Philip W Setel, Sarah B Macfarlane, Simon Szreter, Lene Mikkelsen, Prabhat Jha, Susan Stout, Carla AbouZahr. Lancet 2007
253
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.